Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is more common in Indian men than women, and family history is a strong risk factor.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Women with congenital adrenal hyperplasia showed no prostatic growth.

The case showed the need for quick investigation of virilization in women and how emotional health is linked to physical health.

People often underestimate hair loss severity, with fewer seeking treatment, and it's more distressing for women.

Women have smaller foreheads and different hairline shapes than men.

A postmenopausal woman's excess male hormone symptoms were caused by a rare adrenal gland tissue in her ovary.

Androgenic alopecia is linked to more severe COVID-19 and higher mortality.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Higher myostatin and insulin resistance are linked to androgenetic alopecia.

Certain changes in the SHBG gene may increase the risk of PCOS in Iraqi women.

Androgen-producing ovarian tumors can cause male-pattern hair loss in women.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Women with keloid scars often have acne and hair loss, especially those with "true" keloids, indicating a possible hormonal imbalance.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Patients with androgenetic alopecia often have abnormal lipid levels, so they should be screened and advised on lifestyle changes to prevent heart issues.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

The Fatty Liver Index (FLI) may not be enough to rule out non-alcoholic fatty liver disease in lean women with polycystic ovary syndrome.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Prepubertal girls with hypertrichosis have more sensitive androgen receptors, leading to increased body hair growth.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

The Gabrin sign may help identify COVID-19 patients at high risk who also have hair loss due to male hormones.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

People with early onset baldness (AGA) have higher blood sugar levels and lower sex hormone-binding globulin (SHBG) levels, suggesting SHBG could predict high blood sugar in these individuals.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

Females have a higher lifetime risk of alopecia areata than males.